Cited by 2,707Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Attributes and predictors of long COVID

Open access
Sudre, Carole H., Murray, Benjamin, Varsavsky, Thomas, Graham, Mark S., Penfold, Rose S., Bowyer, Ruth C., Pujol, Joan Capdevila, Klaser, Kerstin +25 more·2021·Nature Medicine

Published version of a preprint

Abstract

Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called 'long COVID', are rising but little is known about prevalence, risk factors or whether it is possible to predict a protracted course early in the disease. We analyzed data from 4,182 incident cases of COVID-19 in which individuals self-reported their symptoms prospectively in the COVID Symptom Study app 1. A total of 558 (13.3%) participants reported symptoms lasting ≥28 days, 189 (4.5%) for ≥8 weeks and 95 (2.3%) for ≥12 weeks. Long COVID was characterized by symptoms of fatigue, headache, dyspnea and anosmia and was more likely with increasing age and body mass index and female sex. Experiencing more than five symptoms during the first week of illness was associated with long COVID (odds ratio = 3.53 (2.76-4.50)). A simple model to distinguish between short COVID and long COVID at 7 days (total sample size, n = 2,149) showed an area under the curve of the receiver operating characteristic curve of 76%, with replication in an independent sample of 2,472 individuals who were positive for severe acute respiratory syndrome coronavirus 2. This model could be used to identify individuals at risk of long COVID for trials of prevention or treatment and to plan education and rehabilitation services.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-021-01292-y

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Post-covid syndrome is characterized by several symptoms affecting quality of life.

    “This is typically referred to as a post-covid syndrome, characterized by several symptoms affecting quality of life (1–5).”

    From Cognitive Behavioral Therapy and Acceptance and Commitment Therapy (CBT-ACT) vs. Standard Care After Critical Illness Due to COVID-19: Protocol for a Pilot Randomized Controlled Trial (2022) · cites this paper as [5]

    The Abstract characterizes long COVID by several symptoms, including fatigue, headache, dyspnea and anosmia; the Results describe additional symptoms. The paper does not report a quality-of-life assessment or establish the claimed effect on quality of life (searched for quality of life and daily functioning). Page numbers were not available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Among reported risk factors of developing long COVID, such as older age, female sex, and underlying comorbidities, the severity of the acute infection is substantial.

    “Among the reported risk factors of developing long COVID, such as older age, female sex, and underlying comorbidities [3,4], the severity of the acute infection is substantial [31,32].”
  • Risk factors for long COVID include older age, female sex, more than five symptoms during acute infection, comorbidities including autoantibodies, and previous psychiatric disorders.

    “Some risk factors for long COVID are older age, female sex, having more than five symptoms during the acute stage of the infection, comorbidities including the presence of autoantibodies, and previous psychiatric disorders.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. Menni, C. et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat. Med. https://doi.org/10.1038/s41591-020-0916-2 (2020). · DOI · Paper page
  2. Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J. & Prescott, H. C. Pathophysiology, transmission, diagnosis and treatment of coronavirus disease 2019 (COVID-19): a review. J. Am. Med. Assoc. 324, 782-793 (2020).
  3. Sheehy, L. M. Considerations for postacute rehabilitation for survivors of COVID-19. JMIR Public Health Surveill. 6, e19462 (2020).
  4. Sudre, C. H. et al. Symptom clusters in COVID-19: a potential clinical prediction tool from the COVID Symptom study app. Preprint at medRxiv https://doi.org/10.1101/2020.06.12.20129056 (2020). · DOI
  5. Mitrani, R. D., Dabas, N. & Goldberger, J. J. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm https://doi.org/10.1016/j.hrthm.2020.06.026 (2020). · DOI
  6. Padda, I., Khehra, N., Jaferi, U. & Parmar, M. S. The neurological complexities and prognosis of COVID-19. SN Compr. Clin. Med. https://doi. org/10.1007/s42399-020-00527-2 (2020). · DOI
  7. National Institute for Health Research. Living with COVID-19. https://doi. org/10.3310/themedreview_41169 (2020). · DOI
  8. Greenhalgh, T., Knight, M., A'Court, C., Buxton, M. & Husain, L. Management of post-acute COVID-19 in primary care. Br. Med. J. 370, m3026 (2020). References

Cited by

Sorted by citations

Authors
Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., Canas, L. S., Molteni, E., Modat, M., Jorge Cardoso, M., May, A., Ganesh, S., Davies, R., Nguyen, L. H., Drew, D. A., Astley, C. M., Joshi, A. D., Merino, J., Tsereteli, N., Fall, T., Gomez, M. F., Duncan, E. L., Menni, C., Williams, F. M. K., Franks, P. W., Chan, A. T., Wolf, J., Ourselin, S., Spector, T., & Steves, C. J.
Affiliations
  • King's College London (GB)
  • ZOE (United Kingdom) (GB)
  • Massachusetts General Hospital (US)
  • Boston Children's Hospital (US)
  • Broad Institute (US)
  • Lund University (SE)
  • Uppsala University (SE)
Corresponding author
Steves, Claire J.
Venue
Nature Medicine
Published
2021-03-10
Volume
27
Issue
4
Pages
626-631
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W3135108774
Cited by
2,707
References
3
Citations by year
2026: 151 · 2025: 289 · 2024: 423 · 2023: 614 · 2022: 748 · 2021: 468 · 2020: 11 · 2018: 1 · 2015: 1
FWCI
269.48
Type
journal article
Language
en
Open access
Locations
  • Nature Medicine (publishedVersion)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • HAL (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • IRIS eCampus Telematic University (Università degli Studi eCampus) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
  • DH | National Institute for Health Research
  • RCUK | Medical Research Council
  • Alzheimer’s Society (AS-JF-17-011)
  • Wellcome Trust
  • Chronic Disease Research Foundation
  • Massachusetts Consortium on Pathogen Readiness (MassCPR) and Mark and Lisa Schwartz
  • European Commission
  • Vetenskapsrådet
  • Stiftelsen för Strategisk Forskning
  • Hjärt-Lungfonden
  • Stuart and Suzanne Steele MGH Research Scholar Award
Topics
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
long COVID, risk factors, symptom duration, fatigue, headache, dyspnea, anosmia, body mass index, sex differences, age, prediction model, SARS-CoV-2
MeSH terms
COVID-19, SARS-CoV-2, Adult, Age Factors, Aged, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review